Account
HepatiSafe by Tesseract Medical Research
Infections, toxin exposures, and oxidative stress can lead to compromised liver function and impaired detoxification, which can often result in non-alcoholic fatty liver disease (NAFLD), a condition that affects 80-100 million U.S. adults. When it is left untreated, NAFLD can cause scarring and fibrosis, and, in extreme cases, untreated NAFLD can lead to cirrhosis and liver failure.
Tesseract’s proprietary transport system enables HepatiSafe’s nutrients to bypass the stomach where acid would otherwise degrade much of their integrity. Tesseract’s DexKey technology releases each molecule of nutrient at the desired release point within the intestinal tract, thus achieving unprecedented absorbability.
This high level of absorption means a lower amount of each active ingredient is required to achieve the preferred efficacious result. This achievement is an integral component of The Tesseract Effect because the ability to micro-dose allows for multiple nutrients to be contained in a single capsule.